, Tracking Stock Market Picks
Enter Symbol:
Cadence Pharmaceuticals, Inc. (CADX) [hlAlert]

down 42.34 %

Cadence Pharmaceuticals, Inc. (CADX) rated Sell with price target $2 by BioLogic Equity Research

Posted on: Wednesday,  Nov 10, 2010  8:25 AM ET by BioLogic Equity Research

BioLogic Equity Research rated Sell Cadence Pharmaceuticals, Inc. (NASDAQ: CADX) on 11/10/2010, when the stock price was $8.06.
Since then, Cadence Pharmaceuticals, Inc. has gained 73.45% as of 03/18/2014's recent price of $13.98.
If you would have followed this BioLogic Equity Research's recommendation on CADX, you would have lost 42.34% of your investment in 1224 days.

Cadence Pharmaceuticals, Inc. is a biopharmaceutical company focused on in-licensing, developing and commercializing its product candidates principally for use in the hospital setting. The Company has in-licensed rights to two late stage product candidates, Acetavance a intravenous formulation of acetaminophen and Omigard (omiganan pentahydrochloride) 1% aqueous gel. It has in-licensed the exclusive United States and Canadian rights to Acetavance, that is marketed in Europe for the treatment of acute pain and fever by Bristol-Myers Squibb Company (BMS). The Company has also in-licensed the rights to commercialize Omigard in North American and Europe.

BioLogic Equity Research is an equity research firm. It focuses its research on healthcare sector including biotechnology, pharmaceuticals, and medical technology. The firm offers event-driven research with a focus on regulatory action dates; new product launches; clinical data releases; and long and short-selling opportunities. It researches early to mid-stage companies and basis the stock selection on high-alpha binary events. The firm employs fundamental analysis to conduct its research. It also provides consulting services. The firm caters to institutional investors. It was formerly known as BioLogic Investment Research LLC. BioLogic Equity Research LLC is based in Delray Beach, Florida.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
11/10/2010 8:25 AM Sell
8.06 2.00
as of 12/31/2010
1 Week up  6.49 %
1 Month down  -0.41 %
3 Months up  10.66 %
1 YTD up  10.66 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy